A newly discovered gene mutation may increase a patient’s risk of genetic heart disease, presenting a target for therapy or genetic screening down the road.
Two Northwestern Medicine scientists have received NIH Director’s Awards, which fund innovative research with high-impact potential.
Northwestern Medicine scientists have discovered surprising findings about an enzyme central to gene expression and mutated in many cancers.
A Northwestern Medicine study found a novel chemical transformation in the formation of colibactin, a toxic agent produced by gut bacteria, including certain strains of E. Coli.
Xinkun Wang, PhD, director of the NUSeq Core Facility, supports the research of scientists throughout the medical school with the latest genomic technologies, including next-generation sequencing.
Northwestern Medicine investigators are on a mission to bring precision medicine to African-Americans.
A comprehensive genomic analysis of the most common kidney cancer in children – found genetic mutations involving two distinct processes, potentially providing new opportunities for future treatments.
The major features of Parkinson’s disease have been linked to a toxic cascade beginning with oxidized dopamine, providing a possible therapeutic pathway.
Northwestern Medicine research has explained the mechanism behind ‘pauses’ in transcription, which has implications for future cancer therapies.
The Graduate Program in Genetic Counseling expanded from 14 to 20 students per class, preparing graduates for careers in various genetic counseling fields, including clinical, industry, research and public policy.